nih public access medicinally-relevant products curr top ......fluorinated organic compounds have a...
TRANSCRIPT
Decarboxylative Fluorination Strategies for AccessingMedicinally-relevant Products
Yupu Qiao, Lingui Zhu, Brett R. Ambler, and Ryan A. AltmanDepartment of Medicinal Chemistry, the University of Kansas, 1251 Wescoe Hall Dr., 4046AMalott Hall, Lawrence, KS 66049, USA
Ryan A. Altman: [email protected]
Abstract
Fluorinated organic compounds have a long history in medicinal chemistry, and synthetic methods
to access target fluorinated compounds are undergoing a revolution. One powerful strategy for the
installation of fluorine-containing functional groups includes decarboxylative reactions. Benefits
of decarboxylative approaches potentially include: 1) readily available substrates or reagents 2)
mild reaction conditions; 3) simplified purification. This focus review highlights the applications
of decarboxylation strategies for fluorination reactions to access compounds with biomedical
potential. The manuscript highlights on two general strategies, fluorination by decarboxylative
reagents and by decarboxylation of substrates. Where relevant, examples of medicinally useful
compounds that can be accessed using these strategies are highlighted.
Keywords
decarboxylation; fluorination; difluoromethylation; trifluoromethylation; copper
1) Introduction
Synthetic methods for the efficient incorporation of fluorinated functional groups enable the
rapid construction of biologically interesting molecules and therefore, are important for
medicinal chemistry [1–2]. Although many creative and elegant fluorination strategies have
recently been developed [3–6], a need remains for new transformations that grant access to
unique products and that rely on principles of green chemistry [7]. One emerging approach
that has gained appreciation in non-fluorine chemistry involves decarboxylative coupling
[8–9]. This strategy typically exhibits several appealing features, including the: 1) use of
inexpensive and readily accessible starting materials; 2) ability to selectively generate
reactive species under mild reaction conditions; 3) release of CO2 as a benign and easily
removed by-product [9]. Given these benefits, decarboxylative coupling represents an
attractive approach for the installation of fluorine and fluorinated functional groups into
organic compounds. The following manuscript discusses historical strategies for
Correspondence to: Ryan A. Altman, [email protected].
CONFLICT OF INTERESTThe author(s) confirm that this article content has no conflicts of interest.
NIH Public AccessAuthor ManuscriptCurr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
Published in final edited form as:Curr Top Med Chem. 2014 ; 14(7): 966–978.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
decarboxylative fluorination to provide a framework for presenting recent developments in
the field. The discussion is divided into two general sections: 1) decarboxylation of reagents
to generate reactive fluorinated species; 2) decarboxylation of substrates to generate reactive
species that can be converted to fluorinated functional groups. Within these two topics, only
reactions that utilize decarboxylation to form new C–F or C–C(F)n bonds are considered.
2) Fluorination by Decarboxylative Reagents
2.1 Introduction to Reagents
The development of reactions that utilize inexpensive, atom-economical reagents represents
a goal of green chemistry [7]. Halodifluoroacetic acids represent an attractive class of
reagents that undergo decarboxylation to release reactive fluorinated species. While
trifluoroacetic acid is the least expensive and most desirable reagent in this class, it
decarboxylates slowly, and has an estimated half-life of 40,000 years at 15 °C in aqueous
solution [10]. Trifluoroacetates have found synthetic utility as fluorinating reagents and will
be discussed later in this section; however, decarboxylation typically requires stoichiometric
Cu and reaction temperatures >150 °C [11–13]. Other halodifluoroacetic acids
decarboxylate more rapidly (Fig. 1); however, metal catalysts, other reagents, and/or high
temperatures are required to facilitate synthetically useful transformations.
In contrast, halodifluoroacetates decarboxylate to generate both :CF2, and in the presence of
F−, −CF3, which can be utilized in a variety of synthetic transformations. The reactivity
trend of halodifluoroacetic acids is consistent for both catalyzed and non-catalyzed
conditions. Bromo-and chlorodifluoroacetates decarboxylate at lower temperatures (50–130
°C), and therefore, are more commonly employed than trifluoroacetates. These milder
conditions allow for increased functional group compatibility, which in turn enables the
installation of fluorinated groups into a broader array of molecules.
The present section focuses on reactions involving the use of halodifluoroacetates as sources
of :CF2 and −CF3, and concludes with discussion of other decarboxylative fluorination
reagents closely related to halodifluoroacetates.
2.2 Decarboxylative Trifluoromethylation of Halodifluoroacetate Esters
Activated alcohols have been converted to trifluoromethanes via a two-step procedure
involving formation of a halodifluoroacetic ester followed by reaction with stoichiometric
CuI in the presence of fluoride (Fig. 2) [14]. Substrates were limited to simple primary
allylic, benzylic, and propargylic alcohols. Allylic and benzylic halodifluoroacetates
underwent formal SN2 substitution, while propargylic chlorodifluoroacetates underwent
formal SN2′ substitution to yield trifluoromethylallenes [14]. Bromodifluoroacetic esters
displayed greater reactivity than chlorodifluoroacetic esters, and produced higher yields (ca.
10%) at 20–30 °C lower reaction temperatures [14]. Most commonly, a two-step procedure
was employed in which an activated alcohol was converted to a halodifluoroacetate,
purified, and then subjected to stoichiometric CuI and KF. A two-step, one-pot procedure
was also developed that utilized ethyl halodifluoroacetates and afforded the product in
moderate to low yield [14].
Qiao et al. Page 2
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
The mechanism of Cu-mediated decarboxylative trifluoromethylation was proposed to
proceed by a multi-step process that involves both CuI and the I− counterion (Fig. 3) [14].
Initially, the halodifluoroacetic ester reacted with CuI to yield an organic iodide and
CuO2CCF2X (Fig. 3A). Next, CuO2CCF2X decarboxylated to generate CuX, CO2, and :CF2
(Fig. 3B). In the presence of KF, an equilibrium was established that formed −CF3 (Fig. 3C).
CuI subsequently reacted with −CF3 to form Cu–CF3 (Fig. 3D). Finally, Cu–CF3 reacted
with the organic iodide to yield the trifluoromethyl product (Fig. 3E). Product was not
formed in the absence of either CuI or KF [14].
This procedure has been employed to access an allylic trifluoromethyl building block, as a
precursor to biologically relevant molecules. In one example, a one-pot, two-step conversion
of an allylic alcohol to an allylic trifluoromethane was employed for the synthesis of the
COX-2 inhibitor, L-784,512 (Fig. 4) [15]. Initial treatment of alcohol 1 with
chlorodifluoroacetic anhydride in the presence of N,N-diisopropylethylamine (DIPEA)
yielded intermediate ester 2. Addition of KF and stoichiometric CuI and heating at 90 °C for
1 h, provided the product trifluoromethane 3 in high yield. Interestingly, DIPEA was critical
for the reaction, as the use of NEt3, pyridine, or K2CO3 resulted in formation of the
corresponding allylic chloride, and 30–60% lower yield of desired product. The one-pot
procedure was more efficient than a two-step procedure in which alcohol 1 was first
converted to an allylic iodide, and subsequently treated with CuI and MeO2CCF2Cl.
Subjection of trifluoromethane 3 to Sharpless asymmetric dihydroxylation, alcohol
oxidation, and coupling/cyclization reactions afforded L-784,512 [15].
Recent research has focused on the development of more green reaction sequences that
utilize catalytic quantities of Cu. Towards this end, the decarboxylative trifluoromethylation
of primary allylic bromodifluoroacetates was conducted in the presence of catalytic CuI
(Fig. 5) [16]. A variety of functional groups were tolerated, including aryl halides, N- and O-
containing functional groups, and a variety of substitution patterns on the alkene. The
system benefited from the use of N,N’-dimethylethylenediamine (DMEDA) as a ligand, and
a catalyst activation procedure in which a solution of CuI, DMEDA, and NaO2CCF2Br were
heated before the addition of substrate. The procedure presumably generated a DMEDA–
Cu–CF3 species that facilitated entry into the catalytic cycle (Fig. 5). The Cu–CF3 species
generated during activation presumably underwent substitution with allylic
bromodifluoroacetate, resulting in the formation of product and DMEDA–Cu–O2CCF2Br.
Decarboxylation and formal halogen exchange allowed catalyst turnover and regeneration of
a DMEDA–Cu–CF3 species. Unlike the proposed mechanism for the Cu-mediated allylic
trifluoromethylation, the mechanism of the Cu-catalyzed reaction did not invoke an allylic
iodide intermediate; control reactions provided comparable yields in the presence and
absence of iodide. For substrates containing Z-alkenes, isomerization to more stable E-
alkene products was observed (Fig. 5). Therefore, this allylic substitution might proceed via
a π–allyl intermediate, which has been invoked to explain substitution reactions of allylic
halides and trifluoroacetates from well defined (PPh3)3Cu–CF3 complexes [17] and Cu–CF3
complexes generated in situ [18].
Qiao et al. Page 3
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
2.3 Aromatic Trifluoromethylation
A series of trifluoromethylating reagents, including halodifluoroacetate salts and esters, and
fluorosulfonyldifluoroacetate salts and esters were developed [19–27], and have been
applied to the trifluoromethylation of aryl and heteroaryl halides (Fig. 6) [19–30]. Generally,
these reagents undergo Cu-mediated decarboxylation of the reagent in situ to release :CF2,
and then react with F− to generate −CF3. Most of these reagents are commercially available,
and those that are not, such as KO2CCF2SO2F, are easily accessible [26]. Historically, aryl
trifluoromethylation reactions with these reagents required high temperatures, stoichiometric
CuI, and polar solvents such as N,N-dimethylformamide (DMF) or N,N-dimethylacetamide
(DMAc). For these reactions, reactivity trends of aryl and heteroaryl halides mimic trends of
other Cu-based coupling reactions (Ar–I > Ar–Br ≫ Ar–Cl) [31]. The introduction of
electron-withdrawing groups, such as NO2, to the aromatic ring can improve the reactivity
of aryl halides, especially aryl chlorides.
Traditionally, decarboxylative aromatic trifluoromethylation required stoichiometric CuI;
however recently, reactions utilizing catalytic CuI were reported [29–30]. In one example,
the Weinreb amide derived from a 5-bromo-2-iodobenzoic acid underwent
trifluoromethylation in the presence of MeO2CCF2SO2F and catalytic CuBr (Fig. 7) [29]. In
this unique example, the amide may have served as a directing group to help facilitate the
reaction. For substrates lacking directing groups, Cu-catalyzed reactions have been achieved
through the use of 1,10-phenanthroline as a ligand (Fig. 7) [30]. Unfortunately, when this
Cu-catalyzed reaction was conducted on a multi-kilogram scale, the formation and
separation of Ar(CF2)nCF3 side products proved problematic [30]. These byproducts
resulted from insertion of :CF2 into Cu–CF3, and were suppressed by reverting to the use of
stoichiometric CuI.
Fluorine-18-labelled organic molecules are used for positron emission tomography (PET)
[32]. Recently, a method of decarboxylative trifluoromethylation enabled the preparation of
Ar–CF3[18F] based PET imaging agents (Fig. 8) [32]. This procedure generated radiolabeled
Cu–[18F]CF3 in situ from MeO2CCF2Cl, CuI, N,N,N’,N’-tetramethylethylenediamine
(TMEDA), and [18F]KF/kryptofix. Under the reaction conditions, a diverse set of aryl and
heteroaryl iodides were rapidly trifluoromethylated. While some medicinally important
functional groups, such as acids and amines, were not compatible with the reaction
conditions, an example of a successful protection strategy was demonstrated by synthesis of
[18F]fluoxetine (selective serotonin reuptake inhibitor) (Fig. 8). Due to the large scope of
substrates and operational simplicity, this transformation should facilitate the drug discovery
process. For more details on PET imaging agents, the reader is referred to an alternate article
[33].
Compared to halodifluoroacetates, trifluoroacetic acid derivatives represent more ideal
reagents for trifluoromethylation, because they are less expensive and do not require the
addition of fluoride to generate −CF3. To this end MeO2CCF3 has served as a
trifluoromethylating reagent in the presence of stoichiometric CuI and promoters, such as
CsF or CsCl [34]. The trifluoromethylation of aryl and heteroaryl halides (the reactivity: ArI
> ArBr ≫ ArCl) using MeO2CCF3 provided the corresponding benzotrifluorides in 42–79%
Qiao et al. Page 4
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
yield, using DMF at 180 °C or sulfolane at 140–180 °C. However, the use of stoichiometric
Cu limits the economic value of the transformation, and the development of a method that
employs only catalytic quantities of a Cu salt represents a desirable target. The CuI-
catalyzed decarboxylative trifluoromethylation of aryl and heteroaryl halides with
MeO2CCF3 using CsF as initiator provided products in 47–95% yield (Fig. 9). To achieve
the catalytic variant, MeO2CCF3 was added at a rate so that the slow decarboxylation step
(k1) matched the consumption of CuCF3 in the aromatic trifluoromethylation step (k2). For
some less active aryl bromides, the use of 1,10-phenanthroline as ligand proved helpful for
the trifluoromethylation reactions [35].
Alkali trifluoroacetate salts are also inexpensive and readily available, and represent
attractive sources of CF3 for large-scale processes. As early as 1981, the decarboxylative
trifluoromethylation of aryl iodides and bromides occurred using NaO2CCF3 in the presence
of CuI [36]. Further investigations confirmed the reactivity of a cuprate, [F3CCuI]−, with
aryl halides to deliver the trifluoromethylated products (Fig. 10A) [11]. Although the use of
the trifluoroacetate salts makes this a desirable protocol for trifluoromethylation, the use of
stoichiometric CuI and high reaction temperature to promote decarboxylation (160–180 °C)
limited the method to reactions of stable substrates. To address this problem, the use of
Ag2O as an additive (30–40 mol%) allowed the analogous CuI-catalyzed reaction of aryl
iodides to occur using NaO2CCF3 at reduced temperature (130 °C) [37]. For this reaction,
the Ag2O was essential, and might lower the activation energy of decarboxylation of sodium
trifluoroacetate to generate AgCF3 in situ (Fig. 10B).
Another commercially available trifluoroacetate salt, KO2CCF3, can also be used in the
trifluoromethylation of aryl and heteroaryl halides. The CuI-mediated trifluoromethylation
of a bromotetrahydronaphthalene with KO2CCF3 afforded the product in 35% yield [38],
and the CuI-mediated trifluoromethylation of N-protected 5-bromoisoindoline with
KO2CCF3, using toluene as co-solvent, provided the desired product in 90% yield [39].
However, the reaction time of the latter was far less than the former (1.5 h vs. 2 d), which
may be attributed to the electron-withdrawing group at the meta-position of the bromide or
the coordinating ability of the –OMe group (Fig. 11).
Chemical reactions conducted in flow microreactors have several advantages over
traditional reaction vessels including: 1) precise control of reaction variables, such as
temperature and rates of mixing; 2) increased safety profiles; 3) the ability to perform
multiple transformations without isolating potentially reactive species [40]. Flow chemistry
has facilitated various fluorination reactions, and recently, enabled the rapid and efficient
trifluoromethylation of aryl and heteroaryl iodides using KO2CCF3 [41]. In the flow reactor,
a solution of KO2CCF3, CuI and pyridine in NMP was mixed with a solution of aryl or
heteroaryl iodides, and the mixture was introduced into a stainless steel tube reactor
submerged in a preheated 200 °C bath using an optimized 16 minutes residence time (Fig.
12). At this point, the mixture was diluted with a stream of ethyl acetate (controlled with a
back regulator), and the resulting mixture was collected and purified to afford
trifluoromethylated arenes in good to excellent yields [41].
Qiao et al. Page 5
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
In addition to the systems described above, trifluoromethylation of aryl halides has been
accomplished using well-defined NHC–Cu–O2CCF3 and –O2CCF2Cl complexes. Upon
heating, the complexes released CO2 and generated NHC–Cu–CF3, which reacted with aryl
electrophiles [42]. When aryl halide was used as the solvent, the ligated copper complex
provided trifluoromethylated products in higher yields than “ligandless” CuI. However,
when the aryl halide was used as only a co-solvent with DMAc, the copper complexes did
not perform superior to reaction of CuI with MO2CCF3 and MO2CCF2Cl (Fig. 13).
2.4 Difluoroolefination
Halodifluoroacetate salts can also serve as regents for difluoroolefination reactions (Fig. 14).
An early one-step synthesis of l,l-difluoroolefins involved heating a solution of an aldehyde,
PPh3 and NaO2CCF2Cl [43].
Three mechanisms were proposed for the conversion of carbonyl compounds to
difluoroolefins (Fig. 15) [44]. Mechanism A would involve the decomposition of
NaO2CCF2Cl to generate :CF2, which would then react with PPh3 to form a phosphonium
ylide. In the presence of a carbonyl compound, the phosphonium ylide could then react via a
Wittig mechanism to form product [43]. Mechanism B involved initial reaction of
NaO2CCF2Cl and PPh3 to generate Ph3P+CF2CO2−. This species would then decarboxylate
to form the common phosphonium ylide species. Finally, mechanism C would involve a
reaction between NaO2CCF2Cl and PPh3 to form an enolate and a phosphonium species,
which would decompose to form a phosphonium ylide.
In order to distinguish between these potential reaction pathways, a series of experiments
were conducted. First, NaO2CCF2Cl and PPh3 were heated in the presence of two :CF2-
trapping reagents, tetramethylethylene and isopropyl alcohol. Formation of
difluorocyclopropane was not observed, which suggested that free :CF2 was not present in
solution [45]. A second experiment monitored the evolution of CO2, when NaO2CCF2Cl
was heated in the presence and absence of PPh3 [45]. The decomposition of the salt was
accelerated in the presence of PPh3, and required only 4–6 h to evolve 70% of the theoretical
amount of CO2. In contrast, the decomposition of the salt in the absence of PPh3 was slow,
and required 17 h to achieve a comparable result. These data were able to discount
mechanism A; however, could not be used to differentiate mechanisms B and C.
The difluoroolefination reaction was later applied to various classes of ketones. For
activated ketones (Fig. 16A), good to excellent yields of difluoroalkenes were obtained
using the standard reaction conditions (PPh3, NaO2CCF2Cl, diglyme, 105 °C) [46];
however, non-activated substrates did not provide substantial quantities of products.
Replacement of PPh3 and diglyme with P(nBu)3 and N-methylpyrrolidone (NMP) (Fig. 16B)
allowed for the extension of the difluoromethylation reaction to some non-activated ketones
[47]; however in some cases, transfer of a butylidine group to the ketone formed a butylidine
side product [48]. Formation of this butylidene product occurred during the reaction with
various electrophilic substrates, including cyclohexanone, heptanal, and
trifluoroacetophenone. In the latter case, only the butylidene product was isolated from the
reaction mixture [48].
Qiao et al. Page 6
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
A rearrangement mechanism was proposed to explain the formation of butylidene product
(Fig. 17) [48]. However, further studies revealed that the butylidene product was directly
formed via reaction of P(nBu)3 and trifluoroacetophenone (Fig. 18) [49].
While earlier researchers favored mechanism B (Fig. 15) (formation of Ph P3P+CF2CO−2,
decarboxylation to provide Ph3P=CF2, then Wittig difluoromethylenation), they were unable
to isolate the key intermediate, Ph3P+CF2CO2−. Recently, the synthesis and characterization
of the key difluoromethylene phosphobetaine provided direct evidence for this reaction
mechanism [50]. To identify the proposed intermediate, PPh3 was reacted with KO2CCF2Br
instead of NaO2CCF2Cl, which allowed for the substitution reaction to proceed under mild
conditions, which allowed for the isolation of Ph3P+CF2CO2− in good yield (Fig. 19).
Ph3P+CF2CO2− was stable to storage in under ambient conditions, and provided a
convenient new reagent for the difluoromethylenation of aldehydes. Moreover, replacement
of PPh3 with P(NMe2)3 provided an alternate reagent, (Me2N)3P+CF2CO2− that reacted well
with non-activated ketones [50].
2.5 Cyclopropanation
Decarboxylative strategies have also been employed for the preparation of fluorinated
cyclopropanes. Early studies showed that thermolysis of NaO2CCF2Cl generated :CF2,
which reacted with cyclohexene to provide 60–65% of the theoretical amount of CO2 in
addition to 22% of difluoronorcarane (Fig. 20) [51].
Later, this strategy was applied to the difluorocyclopropanation of conjugated steroidal
dienes [52]. Both di- and tri-substituted alkenes reacted with :CF2 to provide a mixture of
isomeric adducts (Fig. 21). In addition, the conjugated double bond of an enone system was
also underwent difluorocyclopropanation [53]. However, high temperature 165–225 °C and
large amount of NaO2CCF2Cl (20–50 equiv) were required. Control studies showed that
cyclopropanation did not occur below 150 °C, even though decomposition of the salt
occurred at 125 °C.
This strategy was also applied for difluorocyclopropanation of other nonsteroidal alkenes,
including (Z)-4-(benzyloxy)-2-butenylacetate [54]. However, high temperature (190 °C) and
excesses NaO2CCF2Cl (11 equiv) were required to obtain reasonable yields. Subsequent
Zemplén deacetylation and Mitsunobu reactions allowed for the preparation of a large
number of nucleoside analogues as potential chemotherapeutic agents (Fig. 22A). This
strategy was also amenable to the stereospecific preparation of boron-substituted gem-
difluorocyclopropanes [55], which could be rapidly transformed to afford functionalized
gem-difluorocyclopropanes via lithium carbenoids or by subsequent oxidation (Fig. 22B).
Moreover, this strategy was used to synthesize cis- or trans-4,5-difluoromethanoproline
through difluorocyclopropanation of the aminoacyl derivatives of 4,5-dehydroproline [56].
The two building blocks were stable and could be easily incorporated into the proline-rich
SAP peptide (Fig. 22C). Subsequently, a convenient synthesis of fluorinated cyclopropanes
and cyclopropenes was developed using NaO2CCF2Br as a source of :CF2 [57]. Compared
to NaO2CCF2Cl, NaO2CCF2Br was less hygroscopic at room temperature, and thus, easier
to handle. Further reactions using NaO2CCF2Br were more efficient, and tolerated the
presence of electron-deficient substrates (Fig. 22D).
Qiao et al. Page 7
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
The use of an alternative source of :CF2, trimethylsilyl fluorosulfonyldifluoroacetate
(TFDA), provided access to difluorocyclopropanes under more mild conditions [58] (Fig.
23A). In the presence of catalytic fluoride, TFDA easily decomposed to generate :CF2 (105
°C), and difluorocyclopropanes were obtained in high yields. The moisture-sensitive nature
of TFDA provided a poor shelf life, and made the reagent relatively challenging to handle.
Therefore, a more stable and convenient reagent was designed [59]. This new reagent,
MeO2CCF2SO2F, in combination with KI and TMSCl exhibited comparable reactivity as
TFDA at high concentration and high temperature [60]. Using MeO2CCF2SO2F, a broad
range of alkenes was converted into the corresponding difluorocyclopropanes, even
including unreactive n-butyl acrylate (Fig. 23B). To contrast the usage of MeO2CCF2SO2F
and TFDA, sodium trifluoroacetate can also serve as a precursor to :CF2 [61]. NaO2CCF3
decomposed at 170 °C in the presence of AIBN to form :CF2, which then reacted with a
variety of alkenes. Given the inexpensive nature of NaO2CCF3, this procedure provided an
economical method for difluorocyclopropanation of robust substrates.
Historically, little overlap existed between reactions that generate :CF2 and
difluoromethylene phosponium ylides. MO2CCF2X-based reagents decarboxylated to form
reactive :CF2 species that were used to generate difluorocyclopropanes. In contrast, regents
derived from MO2CCF2X and PPh3 generated difluoromethylene phosphonium ylides for
difluoroolefination reactions. However recently, the interconversion between
difluoromethylene ylide and :CF2 was successfully achieved [62]. By changing the solvent
from DMF to less-polar p-xylene, Ph3P+CF2CO2− was converted from a precursor of
difluoromethylene phosphonium ylide to an efficient precursor of :CF2 (Fig. 19 and 24A). In
contrast, under the corresponding reaction conditions, other reagents only generated the
difluoromethylene phosphonium ylide (Fig. 24B and C). Therefore, Ph3P+CF2CO2− holds
unique status as a reagent that can generate reactive species for both difluoroolefination or
difluorocyclopropanation reactions.
The reactive :CF2 intermediate has also undergone cycloadditions with alkynes to access
strained difluorocyclopropenes. Using this strategy, a number of difluorocyclopropenyl
steroids were synthesized (Fig. 25A) [63]. Difluorocylopropenes were also used as
precursors to biologically active compounds that showed potent insecticidal activities (Fig.
25B) [64]. Using the same strategy, a simple and efficient method for the preparation of 3,3-
difluoroiodocyclopropenes provided access to interesting fluorinated building blocks [65].
In this case, the combination of TDFA and NaF (10 mol%) generated :CF2, which
subsequently reacted with the alkynyl iodide. These new iodides were further functionalized
by: 1) Heck type cross-coupling reactions with α,β-unsaturated compounds; 2)
trifluoromethylation using CuI and TFDA; 3) hydrolysis under acidic conditions to provide
ring opened β-alkyl-β-iodoacrylic acids with exclusive Z-configuration (Fig. 25C).
2.6 Heteroatom Difluoromethylation
Reactive :CF2 intermediates, generated from NaO2CCF2Cl, have also inserted into
heteroatom–H bonds to provide difluoromethylated ethers and amines. At only 95 °C,
NaO2CCF2Cl decarboxylated in the absence of any transition metal catalyst to afford :CF2,
which was directly trapped with a variety of aromatic and heteroaromatic thiols [66].
Qiao et al. Page 8
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Further, the difluoromethylation of nitrogenous heterocycles and phenylselenol were also
successful (Fig. 26).
3) Fluorination and Trifluoromethylation of Substrates that Undergo
Decarboxylation
3.1 Decarboxylation of Acrylic Acid Derivatives
In the preceding section, trifluoromethylation and difluoromethylenation reactions were
realized by decarboxylation of fluorine-based reagents to generate CF3−, :CF2 or F2C=PR3.
Contrary to this strategy, fluoroalkylation and fluorination can also involve decarboxylation
of the substrate in the presence of fluoroalkylating or fluorinating reagents. This developing
strategy already provides medicinal chemists facile access fluoroalkyl-substituted alkenes,
α-trifluoromethyl ketones, alkyl fluorides, and [18F]-labeled di- and tri-fluoromethylated
arenes directly from a vast number of carboxylic acids that already exist in pharmaceutically
important building blocks [67–75].
A series of Cu-mediated decarboxylative fluoroalkylation reactions were developed that
converted α,β-unsaturated [67], β,γ-unsaturated [68], and propargylic [69] carboxylic acids
to fluorinated species using Togni-type electrophilic fluoroalkylating reagents (Fig. 27) [76–
77]. Using the combination of catalytic CuF2 and IIII–CF3 reagents, a variety of α,β-
unsaturated acids were stereoselectively converted to E-vinyl trifluoromethanes [67] (Fig.
27A). Similarly, E-vinyl difluoromethylsulfones could be accessed using a DMEDA–CuII
catalyst system, and an IIII–CF2SO2Ph reagent (Fig. 27B). Allylic difluoromethylsulfones
could also be formed in regioselective fashion from β,γ-unsaturated carboxylic acids (Fig.
27C) [68]. Representative difluoromethylsulfone products could be subjected to reducing
conditions and converted to allylic difluoromethanes, which are difficult to selectively
access using other methods. Finally, propargylic alcohols were converted to
trifluoroethylketones using stoichiometric Cu(OAc)2, DMEDA, and a Togni
trifluoromethylating reagent (Fig. 27D) [69]. This unique result, in which an oxygen atom
originating from water was incorporated into the product, was rationalized by considering
inherent differences in substrate reactivity in the context of the proposed mechanisms.
While the mechanisms of the above decarboxylative fluoroalkylation reactions might share
similar intermediates, distinct properties of the substrates provided discrete products.
According to the proposed mechanisms for both substrates, CuII served as a Lewis acid, and
facilitated the reaction by; 1) increasing the electrophilicity of the Togni-type reagents; 2)
promoting decarboxylation; 3) coordinating substrates and reagents to bring reactive centers
into close proximity. The following mechanism was proposed for the decarboxylative
difluoromethylsulfonylation of α,β-unsaturated acids (Fig. 27E) [67]. DMEDA–CuF2
underwent ligand exchange to form a highly electrophilic species I. Another ligand
exchange would form ternary complex II, thus placing the π–system of the alkene in close
proximity to the iodonium group. Nucleophilic attack by the alkene would generate
carbocationic intermediate III, which could decarboxylate to form vinyl–IIII species IV.
Reductive eliminate would provide product, and a series of ligand exchanges would
regenerate the DMEDA–CuF2 catalyst. When propargylic carboxylic acids were used as
Qiao et al. Page 9
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
substrates, the initial steps of the proposed mechanism would be identical, and intermediate
VI would form (analogous to II) [69]. The more difficult nucleophilic attack of the alkyne in
VI towards the iodonium could alter the mechanism (Fig. 27F). In one case, attack of the
iodonium by π–electrons of the alkyne would provide a high-energy vinyl cation (Path 1).
This species could be quenched with water to form intermediate VII, which would
eventually provide product. An alternate mechanism involved the iodonium acting as a π–
acid to activate the alkyne for nucleophilic attack by H2O (Path 2). Intermediate VII would
then undergo subsequent tautomerization, decarboxylation, and reductive elimination to
form the trifluoroethylketone product [69].
Several complementary decarboxylative methods for the construction of E-configured
Cvinyl–CF3 and Cvinyl–CF2 bonds via radical addition–elimination processes were recently
developed [70–71]. A variety of (heteroaryl)cinnamic acids were converted to vinyl
trifluoromethanes using catalytic CuSO4·5H2O, stoichiometric TBHP, and NaSO2CF3 as a
source of ·CF3 (Fig. 28A). An alternative procedure enabled the conversion of electron-rich
cinnamic acids to difluoromethanes using Fe-catalysis with (CF2HSO2)2Zn (DFMS) as a
source of ·CF2H. While both of these methods utilized mild reaction conditions, the
substrate scope was limited to (heteroaryl)cinnamic acids. Alkyl-substituted acrylic acids
failed to give the desired products, which might arise from the instability of a radical
intermediate. Subsequently, a similar strategy was applied to the FeCl3-mediated
decarboxylative trifluoromethylation of α,β-unsaturated carboxylic acids [71]. A variety of
(heteroaryl)cinnamic acids were compatible with the reaction conditions (Fig. 28B). More
importantly, the reaction could be conducted under an open atmosphere. Decarboxylative
trifluoromethylation of α,β-unsaturated carboxylic acids was also accomplished by
photoredox catalysis [72]. fac-Ir(ppy)3 served as a photocatalyst and generated CF3 from
Togni reagent. The mild reaction conditions provided excellent functional group
compatibility, and moderate to high yields of products were obtained (Fig. 28C).
3.2 Decarboxylation of Aromatic and Aliphatic Acid Derivatives
Recently, the selective fluorination of organic compounds via a radical mechanism was
successfully achieved [73]. In this reaction, decomposition of diacylperoxies or tert-
butylperoxiacids generated organic radicals, which reacted with N-
fluorobenzenesulfonimide (NFSI) to afford alkyl fluorides. This procedure demonstrated
that alkyl radicals could undergo fluorine atom transfer to from alkyl fluorides. A broad
range of alkyl radicals, including primary, secondary, tertiary, benzylic, and heteroatom-
stabilized radicals underwent fluorination. In some cases, the products of the reactions
would have been difficult to access using electrophilic or nucleophilic fluorination
procedures.
Ag-catalyzed decarboxylative fluorinations of carboxylic acids have recently been
developed [74–75]. Aliphatic carboxylic acids were converted to the corresponding alkyl
fluorides using AgNO3 and Selectfluor® in aqueous acetone [74]. A catalytic cycle invoking
AgI, AgII, and AgIII was proposed (Fig. 30A). The mechanism initiated with the reaction of
AgI and Selectfluor® to provide AgIII–F. Single electron transfer then generated AgII–F and
a carboxyl radical, which decarboxylated to form the corresponding alkyl radical. Reaction
Qiao et al. Page 10
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
of AgII–F with the organic radical then provided the fluorinated product [74]. Under similar
reaction conditions, di- and trifluoromethylated arenes were synthesized from readily
available α, α-difluoro- and α-fluoroarylacetic acids (Fig. 30B) [75]. Adaptation of this
system to the usage of [18F]Selectfluor bis(triflate) provided access to 18F-radiolabeled
products. Compared to the usage of [18F]F2, the AgNO3/[18F]Selectfluor bis(triflate) system
offered an expanded scope of substrates and in several examples, provided higher
radiochemical yields.
CONCLUSION
Methods for the synthesis of fluorinated organic compounds are important for medicinal
chemistry as they enable the facile construction of biologically interesting molecules. In
recent years, new methods for the installation of fluorine-containing functional groups have
been developed that utilize powerful strategies, including decarboxylative coupling. As the
field of synthetic organofluorine chemistry continues to advance, decarboxylative coupling
should play an important role in the development of more general, functional-group tolerant,
and practical synthetic methods for the synthesis of fluorinated compounds.
Acknowledgments
We thank the donors of the Herman Frasch Foundation for Chemical Research (701-HF12) and the AmericanChemical Society Petroleum Research Fund (52073-DNI1) for financial support, and the NIGMS Training Grant onDynamic Aspects of Chemical Biology (T32 GM08545) for a graduate traineeship (B. R. A.). Further financialassistance from the University of Kansas Office of the Provost, Department of Medicinal Chemistry, and GeneralResearch Fund (2302264) is gratefully acknowledged.
LIST OF ABBREVIATIONS
AIBN Azobisisobutyronitrile
DCE 1,2-Dichloroethane
DCM Dichloromethane
DIPEA N,N-Diisopropylethylamine
DMAc Dimethylacetamide
DMEDA N N’-Dimethylethylenediamine
DMF Dimethylformamide
DMSO Dimethyl sulfoxide
NFSI N-Fluorobenzenesulfonimide
NMP N-Methyl-2-pyrrolidone
MDFA Methyl 2,2-difluoro-2-(fluorosulfonyl)acetate
TBHP tert-Butyl hydroperoxide
TFA Trifluoroacetic acid
TFDA Trimethylsilyl fluorosulfonyldifluoroacetate
Qiao et al. Page 11
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
TMEDA N,N,N’,N’-Tetramethylethylenediamine
Selectfluor 1-Chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane
bis(tetrafluoroborate)
References
1. Bégué, JP.; Bonnet-Delpon, D. Bioorganic and Medicinal Chemistry of Fluorine. John Wiley &Sons; Hoboken: 2008.
2. Ojima, I., editor. Fluorine in Medicinal Chemistry and Chemical Biology. Blackwell Publishing Ltd;West Sussex: 2009.
3. Liang T, Neumann CN, Ritter T. Introduction of fluorine and fluorine-containing functional groups.Angew Chem Int Ed. 2013; 52:8214–8264.
4. Liu G. Transition metal-catalyzed fluorination of multi carbon–carbon bonds: new strategies forfluorinated heterocycles. Org Biomol Chem. 2012; 10:6243–6248. [PubMed: 22733139]
5. Hollingworth C, Gouverneur V. Transition metal catalysis and nucleophilic fluorination. ChemCommun. 2012; 48:2929–2942.
6. Tomashenko OA, Grushin VV. Aromatic trifluoromethylation with metal complexes. Chem Rev.2011; 111:4475–4521. [PubMed: 21456523]
7. Bryan MC, Dillon B, Hamann LG, Hughes GJ, Kopach ME, Peterson EA, Pourashraf M, Raheem I,Richardson P, Richter D, Sneddon HF. Sustainable practices in medicinal chemistry: current stateand future directions. J Med Chem. 2013; 56:6007–6021. [PubMed: 23586692]
8. Rodríguez N, Goossen LJ. Decarboxylative coupling reactions: a modern strategy for C–C-bondformation. Chem Soc Rev. 2011; 40:5030–5048. [PubMed: 21792454]
9. Weaver JD, Recio A, Grenning AJ, Tunge JA. Transition metal-catalyzed decarboxylative allylationand benzylation reactions. Chem Rev. 2011; 111:1846–1913. [PubMed: 21235271]
10. Lifongo LL, Bowden DJ, Brimblecombe P. Thermal degradation of haloacetic acids in water. Int JPhys Sci. 2010; 5:738–747.
11. Carr GE, Chambers RD, Holmes TF, Parker DG. Sodium perfluoroalkane carboxylates as sourcesof perfluoroalkyl groups. J Chem Soc Perkin Trans I. 1988:921–926.
12. Chang Y, Cai C. Trifluoromethylation of carbonyl compounds with sodium trifluoroacetate. JFluorine Chem. 2005; 126:937–940.
13. McReynolds KA, Lewis RS, Ackerman LKG, Dubinina GG, Brennessel WW, Vicic DA.Decarboxylative trifluoromethylation of aryl halides using well-defined copper-trifluoroacetateand –chlorodifluoroacetate precursors. J Fluorine Chem. 2010; 131:1108–1112.
14. Duan JX, Chen QY. Novel synthesis of 2,2,2-trifluoroethyl compounds from homoallylic alcohols:a copper(I) iodide-initiated trifluoromethyl-dehydroxylation process. J Chem Soc Chem Commun.1994:725–730.
15. Tan L, Chen C-y, Larsen RD, Verhoeven TR, Reider PJ. An efficient asymmetric synthesis of apotent COX-2 inhibitor L-784,512. Tetrahedron Lett. 1998; 39:3961–3964.
16. Ambler BR, Altman RA. Copper-catalyzed decarboxylative trifluoromethylation of allylicbromodifluoroacetates. Org Lett. 2013; 15:5578–5581. [PubMed: 24117395]
17. Larsson JM, Pathipati SR, Szabó KJ. Regio and stereoselective allylic trifluoromethylation andfluorination using CuCF3 and CuF reagents. J Org Chem. 2013; 78:7330–7336. [PubMed:23786623]
18. Miyake Y, Ota S-i, Nishibayashi Y. Copper-catalyzed nucleophilic trifluoromethylation of allylichalides: a simple approach to allylic trifluoromethylation. Chem Eur J. 2012; 18:13255–13258.[PubMed: 22965685]
19. Chen QY, Wu SW. Methyl fluorosulfonyldifluoroacetate: a new trifluoromethylating agent. JChem Soc Chem Commun. 1989:705–706.
20. Chen QY, Yang GY, Wu SW. Copper electron-transfer induced trifluoromethylation with methylfluorosulfonyldifluoroacetate. J Fluorine Chem. 1991; 55:291–298.
Qiao et al. Page 12
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
21. MacNeil JG, Burton DJ. Generation of trifluoromethyl copper from chlorodifluoroacetate. JFluorine Chem. 1991; 55:225–227.
22. Su D-B, Duan J-X, Chen Q-Y. Methyl chlorodifluoroaceate: a convenient trifluoromethylatingagent. Tetrahedron Lett. 1991; 32:7689–7690.
23. Duan J-X, Su D-B, Wu J-P, Chen QY. Synthesis of trifluoromethyl aryl derivatives viadifluorocarbene precursors and nitro-substituted aryl chlorides. J Fluorine Chem. 1994; 66:167–169.
24. Duan J, Su D-B, Chen Q-Y. Trifluoromethylation of organic halides with methylhalodifluoroaceates—a process via difluorocarbene and trifluoromethide intermediates. J FluorineChem. 1993; 61:279–284.
25. Chen QY, Duan JX. Methyl 3-oxo-ω-fluorosulfonylperfluoropentanoate: a versatiletrifluoromethylating agent for organic halides. J Chem Soc Chem Commun. 1993:1389–1391.
26. Long Z-Y, Duan J-X, Lin Y-B, Guo C-Y, Chen Q-Y. Potassium 3-oxo-ω-fluorosulfonylperfluoropentanoate (FO2SCF2CF2OCF2CO2K), a low-temperaturetrifluoromethylating agent for organic halides: it’s α-carbon–oxygen bond fragmentation. JFluorine Chem. 1996; 78:177–181.
27. Chen QY. Trifluoromethylation of organic halides with difluorocarbene precursors. J FluorineChem. 1995; 72:241–246.
28. Roy S, Gregg BT, Gribble GW, Le V-D, Roy S. Trifluoromethylation of aryl heteroaryl halides.Tetrahedron. 2011; 67:2161–2195.
29. Nomura, S.; Kawanishi, E.; Ueta, K. Preparation of glycosides as antidiabetic agents and havinginhibitory activity against sodium-dependent transporter. U.S. Patent Appl Publ US 2012/0258913.2012.
30. Mulder JA, Frutos RP, Patel ND, Qu B, Sun X, Tampone TG, Gao J, Sarvestani M, Eriksson MC,Haddad N, Shen S, Song JJ, Senanayake CH. Development of a safe and economical synthesis ofmethyl 6-chloro-5-(trifluoromethyl)nicotinate: trifluoromethylation on kilogram scale. Org ProcessRes Dev. 2013; 17:940–945.
31. Beletskaya IP, Cheprakov AV. Copper in cross-coupling reactions: the post-Ullmann chemistry.Coord Chem Rev. 2004; 248:2337–2364.
32. Huiban M, Tredwell M, Mitzuta S, Wan Z, Zhang X, Collier TL, Gouverneur V, Passchier J. Abroadly applicable [18F] trifluoromethylation of aryl and heteroaryl iodides for PET imaging.Nature Chem. 2013; 6:941–944. [PubMed: 24153372]
33. Cole EL, Stewart MN, Kittich R, Hoareau R, Scott PJH. Radiosyntheses using Fluorine-18: the Artand Science of Late Stage Fluorination. Curr Top Med Chem. 2014 In Press.
34. Langlois BR, Roeques N. Nucleophilic trifluoromethylation of aryl halides with methyltrifluoroacetates. J Fluorine Chem. 2007; 128:1318–1325.
35. Schareina T, Wu X-F, Zapf A, Cotté A, Gotta M, Beller M. Towards a practical and efficientcopper-catalyzed trifluoromethylation of aryl halides. Top Catal. 2012; 55:426–431.
36. Matsui K, Tobita E, Ando M, Kondo K. A convenient trifluoromethylation of aromatic halideswith sodium trifluoroacetate. Chem Lett. 1981:1719–1720.
37. Li Y, Chen T, Wang H, Zhang R, Jin K, Wang X, Duan C. A ligand-free copper-catalyzeddecarboxylative trifluoromethylation of aryl iodides with sodium trifluoroacetate using Ag2O aspromoter. Syntlett. 2011:1713–1716.
38. Bernstein, P.; Dantzman, C.; Palmer, W. Aryl glycinamide derivatives and their use as NK1antagonists and serotonin reuptake inhibitors. PCT Int Appl. WO 2005/100325. 2005.
39. Austin NE, Avenell KY, Boyfield I, Branch CL, Hadley MS, Jeffrey P, Johnson CN, MacdonaldGJ, Nash DJ, Riley GJ, Smith AB, Stemp G, Thewlis KM, Vong AKK, Wood MD. Design andsynthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamineD3 receptor. Bioorg Med Chem Lett. 2001; 11:685–688. [PubMed: 11266169]
40. Amii H, Nagaki A, Yoshida J-i. Flow microreactor synthesis in organo-fluorine chemistry.Beilstein J Org Chem. 2013; 9:2793–2802. [PubMed: 24367443]
41. Chen M, Buchwald SL. Rapid and efficient trifluoromethylation of aromatic and heteroaromaticcompounds using potassium trifluoroacetates enabled by a flow system. Angew Chem Int Ed.2013; 52:11628–11631.
Qiao et al. Page 13
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
42. McReynolds KA, Lewis RS, Ackerman KG, Dubinina GG, Brennessel WW, Vicic DA.Decarboxylative trifluoromethylation of aryl halides using well-defined copper-trifluoroacetateand -chlorodifluoroacetate precursors. J Fluorine Chem. 2010; 131:1108–1112.
43. Fuqua SA, Duncan WG, Silverstein RM. A one-step synthesis of 1,1-difluoroolefins fromaldehydes by a modified Wittig synthesis. Tetrahedron Lett. 1964; 5:1461–1463.
44. Fuqua SA, Duncan WG, Silverstein RM. A one-step synthesis of 1,1-difluoro olefins fromaldehydes. J Org Chem. 1965; 30:1027–1029.
45. Herkes FE, Burton DJ. Fluoro olefins. I. synthesis of β-substituted perfluoro olefins. J Org Chem.1967; 32:1311–1318.
46. Burton DJ, Herkes FE. A one-step synthesis of β-phenyl substituted perfluoroolefins. TetrahedronLett. 1965:1883–1887.
47. Fuqua SA, Duncan WG, Silverstein RM. A one-step synthesis of 1,1-difluoroolefins from ketones.Tetrahedron Lett. 1965:521–524.
48. Fuqua SA, Duncan WG, Silverstein RM. Synthesis of 1,1-difluoro olefins. II. reactions of ketoneswith tributylphosphine and sodium chlorodifluoroacetate. J Org Chem. 1965; 30:2543–2545.
49. Burton DJ, Herkes FE, Klabunde KJ. The reaction of trifluoromethyl ketones andtrialkylphosphines. J Am Chem Soc. 1966; 88:5042–5043.
50. Zheng J, Cai J, Lin J-H, Guo Y, Xiao J-C. Synthesis and decarboxylative Wittig reaction ofdifluoromethylene phosphobetaine. Chem Commun. 2013; 49:7513–7515.
51. Birchall JM, Cross GE, Haszeldine RN. Difluorocarbene. Proc Chem Soc. 1960; 81
52. Knox LH, Velarde E, Berger S, Cuadriello D, Landis PW, Cross AD. Steroids. CCXXVII.steroidal dihalocyclopropanes. J Am Chem Soc. 1963; 85:1851–1858.
53. Beard C, Dyson NH, Fried JH. The methylenation of unsaturated ketones. Part 1. addition ofdifluoromethylene of enones. Tetrahedron Lett. 1966; 28:3281–3286.
54. Csuk R, Eversmann L. Synthesis of difluorocyclopropyl carbocyclic homo-nucleosides.Tetrahedron. 1998; 54:6445–6456.
55. Fujioka Y, Amii H. Boron-substituted difluorocyclopropanes: new building blocks of gem-difluorocyclopropanes. Org Lett. 2008; 10:769–772. [PubMed: 18225908]
56. Kubyshkin VS, Mykhailiuk PK, Afonin S, Ulrich AS, Komarov IV. Incorporation of cis- andtrans-4,5-difluoromethanoprolines into polypeptides. Org Lett. 2012; 14:5254–5257. [PubMed:23020292]
57. Oshiro K, Morimoto Y, Amii H. Sodium bromodifluoroacetate: a difluorocarbene source for thesynthesis of gem-difluorocyclopropanes. Synthesis. 2010; 12:2080–2084.
58. Tian F, Kruger V, Bautista O, Duan J-X, Li A-R, Dolbier WR Jr, Chen Q-Y. A novel and highlyefficient synthesis of gem-difluorocyclopropanes. Org Lett. 2000; 2:563–564. [PubMed:10814377]
59. Dolbier WR Jr, Tian F, Duan J-X, Li A-R, Ait-Mohand S, Bautista O, Buathong S, Baker JM,Crawford J, Anselme P, Cai XH, Modzelewska A, Koroniak H, Battiste MA, Chen Q-Y.Trimethylsilyl fluorosulfonyldifluoroacetate (TFDA): a new, highly efficient difluorocarbenereagent. J Fluorine Chem. 2004; 125:459–469.
60. Eusterwiemann S, Martinez H, Dolbier WR Jr. Methyl 2,2-difluoro-2-(fluorosulfonyl)acetate, adifluorocarbene reagent with reactivity comparable to that of trimethylsilyl 2,2-difluoro-2-(fluorosulfonyl)acetate (TFDA). J Org Chem. 2012; 77:5461–5464. [PubMed: 22612642]
61. Chang Y, Cai C. Sodium trifluoroacetate: an efficient difluorocarbene precursor for alkenes. ChemLett. 2005; 34:1440–1441.
62. Zheng J, Lin J-H, Cai J, Xiao J-C. Conversion between difluorocarbene and difluoromethyleneylide. Chem Eur J. 2013; 19:15261–15266. [PubMed: 24114936]
63. Crabbe P, Carpio H, Velarde E, Fried JH. Chemistry of difluorocyclopropenes. application to thesynthesis of steroidal allenes. J Org Chem. 1973; 38:1478–1483.
64. Bebia D, Pilorge F, Delbarre LM, Demoute JP. From difluorocyclopropene todifluorocyclopropylidene. Tetrahedron. 1995; 51:9603–9610.
65. Xu W, Chen Q-Y. 3,3-Difluoro-1-iodocyclopropenes: a simple synthesis and their reactions. J OrgChem. 2002; 67:9421–9427. [PubMed: 12492348]
Qiao et al. Page 14
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
66. Mehta VP, Greaney MF. S-, N-, and Se-Difluoromethylation using sodium chlorodifluoroacetate.Org Lett. 2013; 15:5036–5039. [PubMed: 24059700]
67. He Z, Luo T, Hu M, Cao Y, Hu J. Copper-catalyzed di- and trifluoromethylation of α,β-unsaturated carboxylic acids: a protocol for vinylic fluoroalkylations. Angew Chem Int Ed. 2012;51:3944–3947.
68. He Z, Hu M, Luo T, Li L, Hu J. Copper-catalyzed difluoromethylation of β,γ-unsaturatedcarboxylic acids: an efficient allylic difluoromethylation. Angew Chem Int Ed. 2012; 51:11545–11547.
69. He Z, Zhang R, Hu M, Li L, Ni C, Hu J. Copper-mediated trifluoromethylation of propiolic acids:facile synthesis of α-trifluoromethyl ketones. Chem Sci. 2013; 4:3478–3483.
70. Li Z, Cui Z, Liu Z-Q. Copper- and Iron-catalyzed decarboxylative tri- and difluoromethylation ofα,β-unsaturated carboxylic acids with CF3SO2Na and (CF2HSO2)2Zn via a radical process. OrgLett. 2013; 15:406–409. [PubMed: 23305217]
71. Patra T, Deb A, Manna S, Sharma U, Maiti D. Iron-mediated decarboxylative trifluoromethylationof α,β-unsaturated carboxylic acids with trifluoromethanesulfinate. Eur J Org Chem. 2013:5247–5250.
72. Xu P, Abdukader A, Hu K, Cheng Y, Zhu C. Room temperature decarboxylativetrifluoromethylation of α,β-unsaturated carboxylic acids by photoredox catalysis. Chem Commun.201310.1039/C3CC48598F
73. Rueda-Becerril M, Sazepin CC, Leung JCT, Okbinoglu T, Kennephohl P, Paquin J-F, SammisGM. Fluorine transfer to alkyl radicals. J Am Chem Soc. 2012; 134:4026–4029. [PubMed:22320293]
74. Yin F, Wang Z, Li Z, Li C. Silver-catalyzed decarboxylative fluorination of aliphatic carboxylicacids in aqueous solution. J Am Chem Soc. 2012; 134:10401–10404. [PubMed: 22694301]
75. Mizuta S, Stenhagen ISR, O’Duill M, Wolstenhulme J, Kirjavainen AK, Forsback SJ, Tredwell M,Sandford G, Moore PR, Huiban M, Luthra SK, Passchier J, Solin O, Gouverneur V. Catalyticdecarboxylative fluorination for the synthesis of tri- and difluoromethyl arenes. Org Lett. 2013;15:2648–2651. [PubMed: 23687958]
76. Eisenberger P, Gischig S, Togni A. Novel 10-I-3 hypervalent iodine-based compounds forelectrophilic trifluoromethylation. Chem Eur J. 2006; 12:2579–2586. [PubMed: 16402401]
77. Kieltsch I, Eisenberger P, Togni Antonio. Mild electrophilic trifluoromethylation of carbon- andsulfur-centered nucleophiles by a hypervalent iodine(III)-CF3 reagent. Angew Chem Int Ed. 2007;46:754–757.
Qiao et al. Page 15
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (1).Reactivity of halodifluoroacetates.
Qiao et al. Page 16
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (2).Decarboxylative trifluoromethylation of activated halodifluoroacetates.
Qiao et al. Page 17
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (3).Proposed mechanism for CuI-mediated conversion of halodifluoroacetic esters to
trifluoromethanes.
Qiao et al. Page 18
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (4).Decarboxylative trifluoromethylation employed in the synthesis of L-784,512.
Qiao et al. Page 19
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (5).Cu-catalyzed decarboxylative trifluoromethylation.
Qiao et al. Page 20
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (6).Trifluoromethylation of aromatic halides.
Qiao et al. Page 21
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (7).Recent developments in decarboxylative aromatic trifluoromethylation.
Qiao et al. Page 22
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (8).The synthesis of 18F-labelled trifluoromethylated arenes.
Qiao et al. Page 23
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (9).The stoichiometric and catalytic decarboxylative trifluoromethylation of aryl halides using
MeO2CCF3.
Qiao et al. Page 24
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (10).The stoichiometric (A) and catalytic (B) decarboxylative trifluoromethylation of aryl halides
using NaO2CCF3.
Qiao et al. Page 25
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (11).The decarboxylative trifluoromethylation of aryl bromides using KO2CCF3.
Qiao et al. Page 26
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (12).The decarboxylative trifluoromethylation of aromatic halides using KO2CCF3 in a flow
reactor.
Qiao et al. Page 27
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (13).Decarboxylative trifluoromethylation of aryl halides using well-defined copper complexes.
Qiao et al. Page 28
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (14).General strategy of difluoroolefination.
Qiao et al. Page 29
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (15).Mechanisms for the formation of l, l-difluoroolefins.
Qiao et al. Page 30
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (16).Synthesis of 1,l-difluoroolefins from ketones.
Qiao et al. Page 31
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (17).Mechanism for the formation of butylidenecyclohexane.
Qiao et al. Page 32
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (18).Olefination of aryl trifluoromethyl ketones with n-trialkylphosphines.
Qiao et al. Page 33
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (19).gem-Difluoroolefination of aldehydes and ketones.
Qiao et al. Page 34
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (20).Synthesis of difluoronorcarane via :CF2 intermediate.
Qiao et al. Page 35
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (21).Addition of :CF2 to conjugated dienes and enones.
Qiao et al. Page 36
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (22).Synthesis derivatives of difluorocyclopropanes.
Qiao et al. Page 37
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (23).Synthesis of gem-difluorocyclopropanes using TFDA, MeO2CCF2SO2F, and NaO2CCF3 as
sources of :CF2.
Qiao et al. Page 38
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (24).Conversion between :CF2 and difluoromethylene ylide.
Qiao et al. Page 39
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (25).Synthesis of different difluorocyclopropene derivatives.
Qiao et al. Page 40
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (26).Difluoromethylation of thiophenols, nitrogenous heterocycles and phenylselenols.
Qiao et al. Page 41
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (27).Difluoromethylation and trifluoromethylation of unsaturated carboxylic acids.
Qiao et al. Page 42
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (28).Decarboxylative trifluoromethylation of α,β-unsaturated unsaturated carboxylic acids via
radical processes.
Qiao et al. Page 43
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (29).Decarboxyaltive radical fluorination of diacylperxoides and peroxides using N-
fluorobenzenesulfonimide.
Qiao et al. Page 44
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript
Fig. (30).Fluorination of carboxylic acids via radical mechanisms.
Qiao et al. Page 45
Curr Top Med Chem. Author manuscript; available in PMC 2015 January 01.
NIH
-PA
Author M
anuscriptN
IH-P
A A
uthor Manuscript
NIH
-PA
Author M
anuscript